HPA sets 5-year plan

New Health Protection Agency defines its priorities

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LONDON—The new public health organization, the Health Protection Agency (HPA), today set itself a wide range of priorities for the next 5 years, saying the rapid spread of severe acute respiratory syndrome (SARS) highlighted the pressing need for better ways to tackle emerging threats.

"The global threats to health have moved on, and so must we—it's time to step up our health defenses," said HPA Chairman William Stewart, launching the agency's corporate plan on Tuesday (August 5). "The SARS experience demonstrated that a new bug can spread around the world in days."

The agency outlined 12 strategic goals, ranging from boosting preparedness for emergencies through to better understanding of the effects of chronic exposure to environmental chemicals and radiation.

Among the first priorities will be establishing a more systematic approach to "horizon scanning" for anticipating problems, the agency's Chief Executive Pat Troop said at a press conference.

"What we need ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Pincock

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours